| __timestamp | Dr. Reddy's Laboratories Limited | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 9216000000 |
| Thursday, January 1, 2015 | 62786000000 | 8296000000 |
| Friday, January 1, 2016 | 62427000000 | 10044000000 |
| Sunday, January 1, 2017 | 62453000000 | 11560000000 |
| Monday, January 1, 2018 | 65724000000 | 10558000000 |
| Tuesday, January 1, 2019 | 70421000000 | 9351000000 |
| Wednesday, January 1, 2020 | 80591000000 | 8933000000 |
| Friday, January 1, 2021 | 86645000000 | 8284000000 |
| Saturday, January 1, 2022 | 100551000000 | 7952000000 |
| Sunday, January 1, 2023 | 42907000000 | 8200000000 |
| Monday, January 1, 2024 | 115557000000 | 8480000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for two major players: Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited, from 2014 to 2023.
Dr. Reddy's Laboratories consistently outpaced Teva in terms of cost of revenue, with a notable peak in 2024, reaching approximately 115% of its 2014 value. In contrast, Teva's cost of revenue showed a more stable trend, peaking in 2017 and then gradually declining. By 2023, Teva's cost of revenue was about 89% of its 2014 level.
Interestingly, the data for 2024 shows a missing value for Teva, indicating potential reporting delays or strategic shifts. This comparative insight highlights the dynamic nature of cost management in the pharmaceutical sector.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down United Therapeutics Corporation and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue Trends: Incyte Corporation vs Dr. Reddy's Laboratories Limited
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Halozyme Therapeutics, Inc.
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Alkermes plc
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs MorphoSys AG
Dr. Reddy's Laboratories Limited vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.